Matthew L Stoll
Overview
Explore the profile of Matthew L Stoll including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mayer A, Brandon T, Aggarwal A, Burgos-Vargas R, Colbert R, Horneff G, et al.
J Rheumatol
. 2025 Jan;
52(2):165-172.
PMID: 39814440
Objective: To evaluate the influence of pelvic magnetic resonance imaging (MRI) findings on axial disease assessment in juvenile spondyloarthritis (JSpA). Methods: This was a cross-sectional study of patients with JSpA...
2.
Weiss P, Brandon T, Aggarwal A, Burgos-Vargas R, Colbert R, Horneff G, et al.
Arthritis Care Res (Hoboken)
. 2024 Dec;
PMID: 39721765
Objective: The Paediatric Rheumatology International Trials Organisation (PRINTO) recently undertook an effort to better harmonize the pediatric and adult arthritis criteria. These provisional criteria are being refined for optimal performance....
3.
Weiss P, Brandon T, Aggarwal A, Burgos-Vargas R, Colbert R, Horneff G, et al.
Arthritis Rheumatol
. 2024 Jul;
76(12):1797-1808.
PMID: 39039899
Objective: The goal was to develop and validate classification criteria for axial juvenile spondyloarthritis (SpA; AxJSpA). Methods: This international initiative consisted of four phases: (1) item generation, (2) item reduction,...
4.
Srinivasalu H, Simpson J, Stoll M
Curr Opin Rheumatol
. 2024 Apr;
36(4):295-301.
PMID: 38639758
Purpose Of Review: This review summarizes latest developments in treatment of juvenile spondyloarthritis (JSpA), specifically enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA). Recent Findings: There has been addition of...
5.
Reiff D, Stoll M, Cron R
Lancet Rheumatol
. 2024 Feb;
3(11):e808-e817.
PMID: 38297525
The introduction of disease-modifying anti-rheumatic drug therapies for treating children and adolescents with chronic arthritis (ie, juvenile idiopathic arthritis [JIA]) has revolutionised care and outcomes. The biologic revolution continues to...
6.
7.
Reiff D, Bridges J, Rife E, Gennaro V, McAllister L, Reed A, et al.
Pediatr Rheumatol Online J
. 2023 Oct;
21(1):120.
PMID: 37833760
Objective: Pediatric rheumatology faces a looming supply-demand crisis. While strategies have been proposed to address the supply shortfall, investigation into the increased demand for pediatric rheumatic care has been limited....
8.
Gennaro V, Maclin J, Weiser P, Stoll M, Smitherman E
Pediatrics
. 2023 Sep;
152(4).
PMID: 37724393
Juvenile idiopathic arthritis is a common chronic childhood disease, with a prevalence of ∼1 per 1000 children. Arthritis can also be a manifestation of other inflammatory conditions, such as inflammatory...
9.
Huang Y, Sompii-Montgomery L, Patti J, Pickering A, Yasin S, Do T, et al.
Arthritis Care Res (Hoboken)
. 2023 Sep;
76(3):328-339.
PMID: 37691306
Objective: Systemic juvenile idiopathic arthritis-associated lung disease (SJIA-LD) is a life-threatening disease complication. Key questions remain regarding clinical course and optimal treatment approaches. The objectives of the study were to...
10.
Boileau N, Thompson-Phillips K, Goodin B, Lynch-Milder M, Evans C, Adetayo T, et al.
J Pediatr Psychol
. 2023 Jul;
48(10):842-851.
PMID: 37500594
Objective: Many children with chronic musculoskeletal pain conditions experience stigma which can have negative downstream consequences. This study compares ratings of clinical pain (current pain intensity and pain interference), experimental...